COVID–19 NEWS   COVID: Birthday celebration could have created new cluster in Ranau | COVID: 98.3 per cent of 5,726 new cases in categories one and two - Health DG | India reports 12,428 new COVID-19 cases, lowest in 238 days | Malaysia records declining trend in COVID-19 cases since 34th epidemiology week - DG | COVID: Only 12 positive cases in Sarawak needing respiratory support | 

Farmasia, Nucleus Dynamics ink MoA on healthcare informatics

03/04/2018 07:23 PM
KUALA LUMPUR, April 3 (Bernama) -- Malaysian Technology Development Corporation's (MTDC) Business Startup Fund (BSF) recipient, Farmasia Sdn Bhd (Farmasia), and Nucleus Dynamics Pte Ltd (Nucleus Dynamics), today signed a memorandum of agreement (MOA) on healthcare informatics.

The MOA serves as a platform for a paradigm shift in the healthcare industry where a medical device company and an advanced technology company combine forces to add value in enhancing patient care and healthcare outcomes.

It is also set to encourage collaboration among various disciplines within the healthcare community.

Farmasia, a major distributor and manufacturer of medical devices, was represented by its director, Zohrah Razak, while Nucleus Dynamics chief executive officer (CEO), Jasper Tan, signed on behalf of the company.

The MOA signing was witnessed by MTDC CEO, Datuk Norhalim Yunus. Also present was Malaysian Society of Wound Care Professionals president, Prof Dr Harikrishna K.R. Nair.

Farmasia and Nucleus Dynamics will jointly develop and commercialise innovative digital solutions for wound care practitioners  including comprehensive clinical decision support tools that will significantly simplify and standardise wound assessment and treatment.

Nucleus Dynamics, the developer of a cutting-edge digital wound management solution called NDKare, is a Singapore company funded by the National Research Foundation, a department of the Singapore Prime Minister's Office.

Speaking at a media briefing after the MOA signing, Norhalim said collaboration between companies of the two countries would potentially include some technology transfer.

"As MTDC's Business Startup Fund recipient, Farmasia has expanded its foray into the global market with its Dr Wound and Atroxene Flex products," said Norhalim.

Dr Wound is an advanced wound care system to help accelerate healing of acute and chronic wounds, and infected or cavity wounds, while Atrosene Flex Emulgel is a natural-based ozonised extra virgin oil that helps to reduce joints and muscle pain. 


Bernama is the trusted source of reliable real-time comprehensive and accurate news for both the public and media practitioners. Our news is published at ; BERNAMA TV on: Astro Channel 502, unifi TV Channel 631, MYTV Channel 121 IFLIX; and Bernama Radio broadcasting locally on FM93.9 in Klang Valley, Johor (FM107.5), Kota Kinabalu (FM107.9) and Kuching (FM100.9).

Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter :, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial

© 2021 BERNAMA   • Disclaimer   • Privacy Policy   • Security Policy